cennerv pharmaceuticals

Drug developer Cennerv makes second bid to list on Catalist

SINGAPORE-based biotech Cennerv Pharmaceuticals is making a second attempt at an initial public offering (IPO) on the Singapore Exchange's Catalist board, with the lodging of another preliminary...